Indication
Gardnerella vaginalis bacterial vaginosis
Gardnerella vaginalis bacterial vaginosis is a lower genital tract dysbiosis primarily affecting females of reproductive age, characterized by an overgrowth of the facultative anaerobe *Gardnerella vaginalis* alongside other polymicrobial anaerobes. Read more about Gardnerella vaginalis bacterial vaginosis
0 drugs 0 manufacturers
Drugs that treat it
Common Gardnerella vaginalis bacterial vaginosis therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGardnerella vaginalis bacterial vaginosis is a lower genital tract dysbiosis primarily affecting females of reproductive age, characterized by an overgrowth of the facultative anaerobe *Gardnerella vaginalis* alongside other polymicrobial anaerobes.
Pathophysiologically, this proliferation displaces protective, lactic acid–producing *Lactobacillus* species, disrupting normal mucosal defenses and facilitating the formation of an adherent polymicrobial biofilm on the vaginal epithelium.
Clinically, the condition typically presents with an elevated vaginal pH, a thin, homogeneous, grayish-white discharge, a characteristic amine or fish-like odor, and microscopic clue cells, though a substantial portion of affected individuals remain asymptomatic.
Left unmanaged, the disruption in the vaginal microenvironment increases susceptibility to sexually transmitted infections and elevates the risk of adverse obstetric and gynecologic complications, such as preterm labor and pelvic inflammatory disease.
- nih.gov
Gardnerella vaginalis bacterial vaginosis is a lower genital tract dysbiosis primarily affecting females of reproductive age, characterized by an overgrowth of the facultative anaerobe *Gardnerella vaginalis* alongside other polymicrobial anaerobes Pathophysiologically, this proliferation displaces protective, lactic acid–producing *Lactobacillus* species, disrupting normal mucosal defenses and facilitating the formation of an adherent polymicrobial biofilm on the vaginal epithelium Clinically, ...
- cdc.gov
Gardnerella vaginalis bacterial vaginosis is a lower genital tract dysbiosis primarily affecting females of reproductive age, characterized by an overgrowth of the facultative anaerobe *Gardnerella vaginalis* alongside other polymicrobial anaerobes Pathophysiologically, this proliferation displaces protective, lactic acid–producing *Lactobacillus* species, disrupting normal mucosal defenses and facilitating the formation of an adherent polymicrobial biofilm on the vaginal epithelium Clinically, ...
- nih.gov
Gardnerella vaginalis bacterial vaginosis is a lower genital tract dysbiosis primarily affecting females of reproductive age, characterized by an overgrowth of the facultative anaerobe *Gardnerella vaginalis* alongside other polymicrobial anaerobes Left unmanaged, the disruption in the vaginal microenvironment increases susceptibility to sexually transmitted infections and elevates the risk of adverse obstetric and gynecologic complications, such as preterm labor and pelvic inflammatory disease
- cyberderm.net
Pathophysiologically, this proliferation displaces protective, lactic acid–producing *Lactobacillus* species, disrupting normal mucosal defenses and facilitating the formation of an adherent polymicrobial biofilm on the vaginal epithelium
- nih.gov
Clinically, the condition typically presents with an elevated vaginal pH, a thin, homogeneous, grayish-white discharge, a characteristic amine or fish-like odor, and microscopic clue cells, though a substantial portion of affected individuals remain asymptomatic
Personalize your experience
Follow Gardnerella vaginalis bacterial vaginosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.